Shanghai RAAS Blood Products Co Ltd Class A Free Cash Flow Generation Index
Shanghai RAAS Blood Products Co Ltd Class A free cash flow generation index. Shanghai RAAS Blood Products Co Ltd Class A (002252) has a Free Cash Flow Generation Index of 0.92x as of March 2025. Free cash flow of CN¥713.04 Million represents 1% of operating cash flow (CN¥775.56 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Shanghai RAAS Blood Products Co Ltd Class A (2005–2023)
Free cash flow generation index of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2023. Historical FCF Generation Index trend for Shanghai RAAS Blood Products Co Ltd Class A across 18 annual periods. See financial flexibility index of Shanghai RAAS Blood Products Co Ltd Clas to measure the company's free cash flow as a share of total liabilities.
Shanghai RAAS Blood Products Co Ltd Class A Free Cash Flow Generation Index by Year (2005–2023)
Shanghai RAAS Blood Products Co Ltd Class A free cash flow generation index by year from 2005 to 2023. Year-by-year Free Cash Flow Generation Index for Shanghai RAAS Blood Products Co Ltd Class A. For the full cash flow conversion analysis, see how efficiently does Shanghai RAAS Blood Products Co Ltd Clas generate cash.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.80x | CN¥1.83 Billion | CN¥2.28 Billion | CN¥450.80 Million | ▼ -7.7% |
| 2022 | 0.87x | CN¥1.50 Billion | CN¥1.73 Billion | CN¥225.73 Million | ▲ +3.2% |
| 2021 | 0.84x | CN¥1.09 Billion | CN¥1.29 Billion | CN¥204.61 Million | ▲ +7.3% |
| 2020 | 0.78x | CN¥917.09 Million | CN¥1.17 Billion | CN¥251.76 Million | ▼ -4.6% |
| 2019 | 0.82x | CN¥717.86 Million | CN¥872.69 Million | CN¥154.84 Million | ▲ +104.6% |
| 2018 | 0.40x | CN¥105.56 Million | CN¥262.50 Million | CN¥156.94 Million | ▲ +0.9% |
| 2017 | 0.40x | CN¥107.11 Million | CN¥268.76 Million | CN¥157.84 Million | ▼ -48.2% |
| 2016 | 0.77x | CN¥490.74 Million | CN¥638.22 Million | CN¥147.49 Million | ▼ -5.0% |
| 2015 | 0.81x | CN¥617.03 Million | CN¥762.42 Million | CN¥145.39 Million | ▼ -5.9% |
| 2014 | 0.86x | CN¥400.90 Million | CN¥465.96 Million | CN¥65.06 Million | ▲ +99.3% |
| 2012 | 0.43x | CN¥113.77 Million | CN¥263.46 Million | CN¥149.70 Million | ▲ +6138.4% |
| 2011 | 0.01x | CN¥1.23 Million | CN¥178.03 Million | CN¥176.80 Million | ▼ -98.8% |
| 2010 | 0.55x | CN¥111.00 Million | CN¥200.21 Million | CN¥89.21 Million | ▲ +16.9% |
| 2009 | 0.47x | CN¥55.02 Million | CN¥116.01 Million | CN¥60.99 Million | ▼ -34.9% |
| 2008 | 0.73x | CN¥78.41 Million | CN¥107.64 Million | CN¥29.23 Million | ▼ -15.4% |
| 2007 | 0.86x | CN¥151.25 Million | CN¥175.71 Million | CN¥24.46 Million | ▲ +11.1% |
| 2006 | 0.77x | CN¥41.50 Million | CN¥53.58 Million | CN¥12.08 Million | ▲ +29.4% |
| 2005 | 0.60x | CN¥32.32 Million | CN¥54.02 Million | CN¥21.69 Million | — |